Canada (CA)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer (2024) Nelson BH, Hamilton P, Phung MT, Milne K, Harris B, Thornton S, Stevens D, et al. Journal article Spin foam amplitude of the black-to-white hole transition (2024) Han M, Qu D, Zhang C Journal article Federated Artificial Resampling for Imbalanced Facial Emotion Recognition (2024) Chatterjee S, Ghosh K, Bhattacharjee S, Das AK, Banerjee S Journal article Data-driven modelling of hydraulic-head time series: results and lessons learned from the 2022 Groundwater Time Series Modelling Challenge (2024) Collenteur RA, Haaf E, Bakker M, Liesch T, Wunsch A, Soonthornrangsan J, White J, et al. Journal article Corner symmetry and quantum geometry (2024) Freidel L, Geiller M, Wieland W Book chapter / Article in edited volumes Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder (2024) Herrera-Rivero M, Gutiérrez-Fragoso K, Kurtz J, Baune BT, Thalamuthu A, Amare AT, Adli M, et al. Journal article Exploring the genetics of lithium response in bipolar disorders (2024) Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare AT, Ardau R, Arias B, et al. Journal article Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study (2024) Ou AH, Rosenthal SB, Adli M, Akiyama K, Akula N, Alda M, Amare AT, et al. Journal article Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: Analysis of routinely collected data with emulation of a reference trial (ONTARGET) (2024) Baptiste PJ, Wong AY, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article